Abstract: A support powder can improve cell performance under high humidity environment. A support and metal catalyst, including: a support powder; and metal fine particles supported on the support powder; wherein: the support powder is an aggregate of support fine particles; the support fine particles are fine particles of oxide compound and has a chained portion structured by a plurality of crystallites being fusion bonded to form a chain; the crystallites have a size of 10 to 30 nm; the support powder has a void; the void includes a secondary pore having a pore diameter of more than 25 nm and 80 nm or less determined by BJH method; and a volume of the secondary pore per unit volume of the support fine particles structuring the support powder is 0.313 cm3/cm3 or more, is provided.

Abstract: A support powder can improve cell performance under high humidity environment. A support and metal catalyst, including: a support powder; and metal fine particles supported on the support powder; wherein: the support powder is an aggregate of support fine particles; the support fine particles are fine particles of oxide compound and has a chained portion structured by a plurality of crystallites being fusion bonded to form a chain; the crystallites have a size of 10 to 30 nm; the support powder has a void; the void includes a secondary pore having a pore diameter of more than 25 nm and 80 nm or less determined by BJH method; and a volume of the secondary pore per unit volume of the support fine particles structuring the support powder is 0.313 cm3/cm3 or more, is provided.

Abstract: A positive electrode active material for lithium secondary batteries has excellent charge-discharge cycle characteristics and high capacity when used as a positive electrode material. A nonaqueous electrolyte lithium secondary battery includes a Li—Ni—Co—Al composite oxide, wherein the initial discharge capacity when discharging at a measurement temperature of 20° C., a discharge rate of 0.1 C, and a voltage range of 4.25-2.5 V inclusive is 192 mAh/g or more; the discharge capacity hold rate when repeatedly charged and discharged 100 times under the same conditions is 94% or more; and the composite oxide particles have an aspect ratio equal to or greater than 0.9. An aqueous solution of a Ni compound and a Co compound is stirred in a N2 gas atmosphere while adding alkali, which are then subjected to dehydration and drying and subsequently dry-blended with Li and Al compounds, after which the resulting product is baked in an oxidizing atmosphere.

Abstract: In a treatment process for a positive electrode active material for a lithium-ion secondary battery, Li compounds such as Li2CO3, LiOH, and the like, present in a positive electrode active material for a lithium-ion secondary battery but unsuitable for a positive electrode material, is removed. In a case wherein the resultant Li compound is used as a positive electrode material of the secondary battery, a discharge capacity and an average discharge voltage of the secondary battery do not decline, and gelation caused by a cleaning treatment is prevented. The positive electrode active material is cleaned with a cleaning fluid containing NH3, and then solid-liquid separation is performed, and a solid component is calcined at 600 to 700° C. in an oxygen atmosphere. The cleaning fluid has a conductivity of 11.6 mS/cm or less, and contains a recovered liquid component and may be repeatedly used as a cleaning fluid.

Abstract: In a treatment process for a positive electrode active material for a lithium-ion secondary battery, Li compounds such as Li2CO3, LiOH, and the like, present in a positive electrode active material for a lithium-ion secondary battery but unsuitable for a positive electrode material, is removed. In a case wherein the resultant Li compound is used as a positive electrode material of the secondary battery, a discharge capacity and an average discharge voltage of the secondary battery do not decline, and gelation caused by a cleaning treatment is prevented. The positive electrode active material is cleaned with a cleaning fluid containing NH3, and then solid-liquid separation is performed, and a solid component is calcined at 600 to 700° C. in an oxygen atmosphere. The cleaning fluid has a conductivity of 11.6 mS/cm or less, and contains a recovered liquid component and may be repeatedly used as a cleaning fluid.

Abstract: The present invention provides 2-aminoquinazoline derivatives represented by formula (I): wherein R1 and R2 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, and the like; X represents a bond or CR7aR7b wherein R7a and R7b may be the same or different and each represents a hydrogen atom, and the like; when X is a bond, R3 represents substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group; when X is CR7aR7b wherein R7a and R7b have the same meanings as defined above, respectively, R3 represents substituted or unsubstituted lower alkoxy, substituted or unsubstituted aryl, and the like; R4 represents a hydrogen atom, hydroxy, substituted or unsubstituted lower alkoxy, and the like; and R5 represents a hydrogen atom, substituted or unsubstituted aryl, and the like, or a pharmaceutically acceptable salt thereof.

Abstract: A 2-aminoquinazoline derivative represented by formula (I) {wherein R1 represents a hydrogen atom, or the like, R2 represents a hydrogen atom, R3 represents formula (II) [wherein A1 represents formula (III), or the like, R8 represents lower alkyl, or the like, and R9 represents optionally substituted aryl, or the like], R4 represents hydroxy, or the like, and R5 represents optionally substituted aryl, or the like}, or a pharmaceutically acceptable salt thereof is provided.

Abstract: The present invention provides 2-aminoquinazoline derivatives represented by formula (I): wherein R1 and R2 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, and the like; X represents a bond or CR7aR7b wherein R7a and R7b may be the same or different and each represents a hydrogen atom, and the like; when X is a bond, R3 represents substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group; when X is CR7aR7b wherein R7a and R7b have the same meanings as defined above, respectively, R3 represents substituted or unsubstituted lower alkoxy, substituted or unsubstituted aryl, and the like; R4 represents a hydrogen atom, hydroxy, substituted or unsubstituted lower alkoxy, and the like; and R5 represents a hydrogen atom, substituted or unsubstituted aryl, and the like, or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides an &agr;2c-adrenoceptor antagonist comprising, as an active ingredient, a condensed-ring-pyrimidine derivative represented by general formula (I) below or a pharmaceutically acceptable salt thereof useful for treating and/or preventing various diseases induced by hyperactivity of &agr;2c-adrenoceptor (for example, Parkinson's disease, L-DOPA-induced dyskinesia, tardive dyskinesia and depression) and the like.